Actively Recruiting
Strategies for Improving Linkage-to-Care After Eye Disease Screening
Led by University of California, San Francisco · Updated on 2026-04-29
3000
Participants Needed
1
Research Sites
125 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
S
Seva Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.
CONDITIONS
Official Title
Strategies for Improving Linkage-to-Care After Eye Disease Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant of the VIEW II study referred to the eye hospital at their eye screening visit.
You will not qualify if you...
- Residence in an area without reliable mobile connectivity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, San Francisco
San Francisco, California, United States, 94158
Actively Recruiting
Research Team
J
Jeremy Keenan, MD, MPH
CONTACT
K
Krisianne Aromin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here